CCR5 and HIV infectious disease: Single-chain variable fragments (scFvs) derived from broadly neutralizing anti-HIV antibodies, integrated into the T cell CCR5 locus, conferred potent lytic activity against HIV-infected cells both in vitro and in a PBMC-humanized mouse model of HIV infection [123].